若您需要咨询产品或有任何技术问题,请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系。

Latrunculin A

抑制肌动蛋白聚合

只有 %1
¥2,230.00

产品号 #(选择产品)

产品号 #100-0562_C

抑制肌动蛋白聚合

总览

Latrunculin A是一种从红海海绵Latrunculia magnifica中分离得到的2-噻唑烷酮大环内酯类化合物(Coué et al.)。它能与单体G-肌动蛋白形成1:1摩尔比的复合物,并在体外抑制肌动蛋白聚合(Kd = 0.2 μM;Coué et al.)。肌动蛋白对多种细胞功能至关重要,例如内吞作用、细胞迁移和肿瘤侵袭。本产品以100 μg/mL的乙醇溶液形式提供。

癌症研究

· 破坏肿瘤细胞中的肌动蛋白细胞骨架(Hayot et al.)。

别名
NSC 613011
 
细胞类型
癌细胞及细胞系
 
研究领域
癌症
 
CAS 编号
76343-93-6; 64-17-5
 
化学式
C22H31NO5S
 
分子量
421.6 g/mol
 
纯度
≥ 95 %
 

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Product Name
Latrunculin A
Catalog #
100-0562, 100-0563
Lot #
All
Language
English
Document Type
Safety Data Sheet
Product Name
Latrunculin A
Catalog #
100-0562, 100-0563
Lot #
All
Language
English

Resources and Publications

Educational Materials (2)

Publications (2)

Characterization of the activities of actin-affecting drugs on tumor cell migration. C. Hayot et al. Toxicology and applied pharmacology 2006 feb

Abstract

Metastases kill 90{\%} of cancer patients. It is thus a major challenge in cancer therapy to inhibit the spreading of tumor cells from primary tumor sites to those particular organs where metastases are likely to occur. Whereas the actin cytoskeleton is a key component involved in cell migration, agents targeting actin dynamics have been relatively poorly investigated. Consequently, valuable in vitro pharmacological tools are needed to selectively identify this type of agent. In response to the absence of any standardized process, the present work aims to develop a multi-assay strategy for screening actin-affecting drugs with anti-migratory potentials. To validate our approach, we used two cancer cell lines (MCF7 and A549) and three actin-affecting drugs (cytochalasin D, latrunculin A, and jasplakinolide). We quantified the effects of these drugs on the kinetics of actin polymerization in tubes (by means of spectrofluorimetry) and on the dynamics of actin cytoskeletons within whole cells (by means of fluorescence microscopy). Using quantitative videomicroscopy, we investigated the actual effects of the drugs on cell motility. Finally, the combined drug effects on cell motility and cell growth were evaluated by means of a scratch-wound assay. While our results showed concordant drug-induced effects on actin polymerization occurring in vitro in test tubes and within whole cells, the whole cell assay appeared more sensitive than the tube assay. The inhibition of actin polymerization induced by cytochalasin D was paralleled by a decrease in cell motility for both cell types. In the case of jasplakinolide, which induces actin polymerization, while it significantly enhanced the locomotion of the A549 cells, it significantly inhibited that of the MCF-7 ones. All these effects were confirmed by means of the scratch-wound assay except of the jasplakinolide-induced effects on MCF-7 cell motility. These later seemed compensated by an additional effect occurring during wound recolonization (possibly acting on the cell growth features). In conclusion, the use of multi-assays with different levels of sophistication and biological relevance is recommended in the screening of new actin-affecting drugs with potentially anti-migratory effects.
Inhibition of actin polymerization by latrunculin A. M. Cou\'e et al. FEBS letters 1987 mar

Abstract

Latrunculin A, a toxin purified from the red sea sponge Latrunculia magnifica, was found previously to induce striking reversible changes in the morphology of mammalian cells in culture and to disrupt the organization of their microfilaments. We now provide evidence that latrunculin A affects the polymerization of pure actin in vitro in a manner consistent with the formation of a 1:1 molar complex between latrunculin A and G-actin. The equilibrium dissociation constant (Kd) for the reaction in vitro is about 0.2 microM whereas the effects of the drug on cultured cells are detectable at concentrations in the medium of 0.1-1 microM.

更多信息

更多信息
Molecular Weight 421.6 g/mol
Alternative Names NSC 613011
Cas Number 76343-93-6; 64-17-5
Chemical Formula C22H31NO5S
纯度 ≥ 95 %

质量声明:

产品仅供研究使用,不用于针对人或动物的诊断或治疗。 欲获悉更多关于STEMCELL的质控信息,请访问 STEMCELL.CN/COMPLIANCE.

Copyright © 2026 by STEMCELL Technologies. All rights reserved.

在线联系